XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2022   289,014,487        
Beginning balance at Dec. 31, 2022 $ 573,454 $ 2,890 $ 1,030,466 $ (89,740) $ (370,866) $ 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 94,175       94,175  
Other comprehensive loss 1,912     1,912    
Dividends declared (29,224)       (29,224)  
Shares issued in connection with deferred compensation plan, net (in shares)   2,782,181        
Shares issued in connection with deferred compensation plan, net (36,329) $ 28 (28)   (36,329)  
Deferred compensation plan elective participant deferrals 1,651   1,651      
Shares issued in connection with executive bonus plan, net (in shares)   137,197        
Shares issued in connection with executive bonus plan, net 5,480 $ 2 9,804   (4,326)  
Shares issued in connection with employee stock purchase plan, net (in shares)   153,381        
Shares issued in connection with employee stock purchase plan, net 4,335 $ 1 4,556   (222)  
Stock option exercises, net (in shares)   2,236,827        
Stock option exercises, net 3,711 $ 22 9,678   (5,989)  
Shares issued for stock grants, net (in shares)   12,639        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 28,343   28,343      
Shares related to restricted stock, net (in shares)   376,271        
Shares related to restricted stock, net (4,336) $ 4 (4)   (4,336)  
Ending balance (in shares) at Jun. 30, 2023   294,712,983        
Ending balance at Jun. 30, 2023 643,772 $ 2,947 1,085,066 (87,828) (357,117) 704
Beginning balance (in shares) at Mar. 31, 2023   291,501,271        
Beginning balance at Mar. 31, 2023 614,190 $ 2,915 1,060,842 (89,374) (360,897) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 48,685       48,685  
Other comprehensive loss 1,546     1,546    
Dividends declared (14,702)       (14,702)  
Shares issued in connection with deferred compensation plan, net (in shares)   1,729,443        
Shares issued in connection with deferred compensation plan, net (22,703) $ 17 (17)   (22,703)  
Deferred compensation plan elective participant deferrals 118   118      
Shares issued in connection with executive bonus plan, net (in shares)   57,393        
Shares issued in connection with executive bonus plan, net 2,421 $ 1 4,321   (1,901)  
Stock option exercises, net (in shares)   1,308,527        
Stock option exercises, net 1,210 $ 13 5,485   (4,288)  
Shares issued for stock grants, net (in shares)   12,639        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 13,718   13,718      
Shares related to restricted stock, net (in shares)   103,710        
Shares related to restricted stock, net (1,311) $ 1 (1)   (1,311)  
Ending balance (in shares) at Jun. 30, 2023   294,712,983        
Ending balance at Jun. 30, 2023 643,772 $ 2,947 1,085,066 (87,828) (357,117) 704
Beginning balance (in shares) at Dec. 31, 2023   296,265,837        
Beginning balance at Dec. 31, 2023 883,982 $ 2,963 1,127,234 (84,987) (161,932) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 142,356       142,356  
Other comprehensive loss (8,277)     (8,277)    
Dividends declared (35,851)       (35,851)  
Shares issued in connection with deferred compensation plan, net (in shares)   2,474,063        
Shares issued in connection with deferred compensation plan, net 0 $ 24 (24)      
Deferred compensation plan elective participant deferrals 101   101      
Shares issued in connection with executive bonus plan, net (in shares)   168,291        
Shares issued in connection with executive bonus plan, net 8,916 $ 2 8,914      
Shares issued in connection with employee stock purchase plan, net (in shares)   122,020        
Shares issued in connection with employee stock purchase plan, net 5,385 $ 1 5,559   (175)  
Stock option exercises, net (in shares)   844,283        
Stock option exercises, net 1,812 $ 8 3,999   (2,195)  
Shares issued for stock grants, net (in shares)   11,391        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 30,253   30,253      
Shares related to restricted stock, net (in shares)   590,929        
Shares related to restricted stock, net (7,256) $ 6 (6)   (7,256)  
Repurchases of Class B common stock under approved program (in shares)   (729,681)        
Repurchases of Class B common stock under approved program (37,515) $ (7)     (37,508)  
Ending balance (in shares) at Jun. 30, 2024   299,747,133        
Ending balance at Jun. 30, 2024 984,506 $ 2,997 1,176,630 (93,264) (102,561) 704
Beginning balance (in shares) at Mar. 31, 2024   298,014,682        
Beginning balance at Mar. 31, 2024 932,607 $ 2,980 1,154,137 (92,619) (132,595) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 72,046       72,046  
Other comprehensive loss (645)     (645)    
Dividends declared (17,980)       (17,980)  
Shares issued in connection with deferred compensation plan, net (in shares)   1,936,318        
Shares issued in connection with deferred compensation plan, net 0 $ 19 (19)      
Deferred compensation plan elective participant deferrals 43   43      
Shares issued in connection with executive bonus plan, net (in shares)   102,352        
Shares issued in connection with executive bonus plan, net 5,565 $ 1 5,564      
Shares issued for stock grants, net (in shares)   11,391        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 16,306   16,306      
Shares related to restricted stock, net (in shares)   109,473        
Shares related to restricted stock, net (1,527) $ 1 (1)   (1,527)  
Repurchases of Class B common stock under approved program (in shares)   (427,083)        
Repurchases of Class B common stock under approved program (22,509) $ (4)     (22,505)  
Ending balance (in shares) at Jun. 30, 2024   299,747,133        
Ending balance at Jun. 30, 2024 $ 984,506 $ 2,997 $ 1,176,630 $ (93,264) $ (102,561) $ 704